Attendee Syllabus

3rd Annual Cardiovascular Disease Management for Nurses | October 10, 2018

Cardiovascular Disease Management: A Case-Based Approach | October 11 – 12, 2018

General Course Materials:

Updated Scientific Program

Faculty Information – Sponsorship – Accreditation – Disclosures


The faculty presentations, when approved by the speaker(s), will be posted below within 24 hours of presentation.

3rd Annual Cardiovascular Disease Management for Nurses

Wednesday, October 10, 2018

Clinical Nursing Series: Care of the Patient with Heart Failure (HF/CHF)

Curtis Townsend, RN, BSN

Decreasing Readmission Rates for HF and MI

Sharon Morgan, DNP, FNP-BC, AGACNP-BC

Quality Improvement and Your Cardiology Service Line

Maghee Disch, MSN, RN, FHFSA, CHFN, AACC

HTN Management Strategies

Marci Farquhar-Snow, MN, RN, CCRN, CMC, ACNP-BC, AACC


6th Annual Cardiovascular Disease Management: A Case-Based Approach

Thursday, October 11, 2018

Slides will be posted within 24 hours of presentation when approved by the speaker.

Arizona Chapter of the American College of Cardiology

Christian S. Breburda, MD, PhD, FACC

Nearly 50% of Americans Have Hypertension: What Are the New Guidelines?

Michael Weber, MD, FACC

Are We Recognizing all of the Treatable Causes of Hypertension: Primary Hyperaldosteronism, Recognition and Treatment

J. Brian Byrd, MD, MS

Now That Coronary Artery Disease is Being Managed, We Have A CHF Epidemic: New Agents and New Promises

Nancy Sweitzer, MD, PhD, FACC

Abdominal and Thoracic Aneurysmal Disease:  Best Treated Percutaneously:  State-of-the-Art

(PDF Part 1)(PDF Part 2)(PDF Part 3)

John Laird, MD, FACC

Finally the Feds Will Allow Us to Treat Paradoxical Emboli Leading to Strokes…What About PFO Closure and Migraines?  Is There Convincing Evidence to Treat?

 Robert Sommer, MD

Venous Disease is Extremely Prevalent and Way Under Diagnosed and Treated:  Outlook From a Pioneer

Patricia E. Thorpe, MD, FSIR

PCI Post ORBITA: Does This Really Change Our Treatment of Chronic Stable Angina?    

Kirk N. Garratt, MSc, MD, FACC


Friday, October 12, 2018

What About All These New Diabetic Medications:  Which Ones Can Make an Impact on Cardiovascular Disease in My Diabetic Patients?

George Dailey, MD, MACE

 New Treatments for PAD:  What Practitioners Need to Know

John Laird, MD, FACC

Wound Care From a Podiatrist’s Perspective:  What Do Practitioners Need to Know?

Alan Block, DPM, MS, FACFAS, FASPS

With the Explosion in Growth of CHF in the US, What is the Role of an Outpatient Oriented CHF Clinic in Your Practice?

Nancy Sweitzer, MD, PhD, FACC

Introduction and Advances in Digital Medicine

Raj Khandwalla, MD, MA, FACC

TAVR is Here to Stay:  What About TAVR in Low-Risk Patients?

Joseph Carrozza, MD, FACC